Anesthetic

Federal Court Enters Consent Decree Against Pharmasol for Distributing Adulterated Drugs

Retrieved on: 
Thursday, December 14, 2023
China Biologic Products, Safety, Heated tobacco product, Anesthetic, Justice, Complaint, Risk, Patient, Multimedia, Research, FDA, Animal, Vaccine, Health, Cosmetics, District court, Human services, Dietary supplement, Food, Failure, FD, Public, Pharmaceutical industry, Medical device, Badia

According to the complaint, which was filed along with the consent decree by the U.S. Department of Justice, Pharmasol and Badia unlawfully distributed adulterated drugs, meaning they do not comply with manufacturing quality requirements within the U.S. marketplace.

Key Points: 
  • According to the complaint, which was filed along with the consent decree by the U.S. Department of Justice, Pharmasol and Badia unlawfully distributed adulterated drugs, meaning they do not comply with manufacturing quality requirements within the U.S. marketplace.
  • In this case, the defendant's company distributed adulterated, poor-quality drugs without regard for patients and consumers," said Jill Furman, director of the Office of Compliance in the FDA's Center for Drug Evaluation and Research.
  • Pharmasol manufactures and distributes over-the-counter drugs, as well as human and animal prescription drugs such as topical corticosteroids and inhalant anesthetics.
  • According to the complaint, the defendants violated federal law under the FD&C Act by introducing drugs into interstate commerce that fail to comply with current good manufacturing practice requirements; therefore, these drugs are adulterated.

AANA Publishes Practice Considerations for Care of Transgender and Gender-Diverse Patients

Retrieved on: 
Thursday, November 16, 2023
Agent handling, Respiration, Policy, Anesthesia, DNP, Anesthetic, Pain management, Patient, Multimedia, Anesthesiology, Preoperative care, Certified Registered Nurse Anesthetist, Surgery, Trauma, CPPS, Nursing

ROSEMONT, Ill., Nov. 16, 2023 /PRNewswire/ -- To help ensure that all patients receive high-quality, safe pain management and anesthesia care, the American Association of Nurse Anesthesiology (AANA) has published its practice considerations for care of transgender and gender-diverse patients .

Key Points: 
  • ROSEMONT, Ill., Nov. 16, 2023 /PRNewswire/ -- To help ensure that all patients receive high-quality, safe pain management and anesthesia care, the American Association of Nurse Anesthesiology (AANA) has published its practice considerations for care of transgender and gender-diverse patients .
  • "The purpose of these practice and policy considerations is to highlight the impact of health inequities for transgender patients and how these may affect care outcomes.
  • The AANA recommends the personalized care during preoperative care also be applied to postoperative care for transgender patients.
  • AANA embraces members of the LGBTQIA+ community, including transgender and gender-diverse patients, and recognizes that nurse anesthesiologists play an integral role in promoting quality healthcare for these patients.

American Association of Nurse Anesthesiology Named a Winner of the Chicago Tribune's Top Workplaces 2023 Award

Retrieved on: 
Wednesday, November 15, 2023
Holiday, CAE, Interface (computing), Anesthesia, Certified Registered Nurse Anesthetist, Workplace, Anesthetic, New Year's Day, Patient, Culture, EI Leadership Institute, MBA, Christmas, Human, Nursing

ROSEMONT, Ill. , Nov. 15, 2023 /PRNewswire/ -- The American Association of Nurse Anesthesiology (AANA) has been awarded a Top Workplaces 2023 honor by Chicago Tribune Top Workplaces.

Key Points: 
  • ROSEMONT, Ill. , Nov. 15, 2023 /PRNewswire/ -- The American Association of Nurse Anesthesiology (AANA) has been awarded a Top Workplaces 2023 honor by Chicago Tribune Top Workplaces.
  • The list is based solely on employee feedback gathered through a third-party survey administered by employee engagement technology partner Energage LLC.
  • "Earning a Top Workplaces award is a badge of honor for companies, especially because it comes authentically from their employees," said Eric Rubino, Energage CEO.
  • Founded in 1931, AANA is the professional organization representing nearly 61,000 Certified Registered Nurse Anesthetists (CRNAs) and resident registered nurse anesthetists across the United States.

Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15

Retrieved on: 
Tuesday, November 7, 2023
Biotechnology, Medical Devices, Health, Clinical Trials, Medical Supplies, Sale, Aortoiliac occlusive disease, DCB, Cell, Sundance, ISET, Master of Medicine, Freedom, Restenosis, Safety, PHD, Ambient occlusion, PP, MS, Pharmaceutical industry, MBBS, Anesthetic, FRACS

The session will be held on Wednesday, November 15th, at the 50th annual VEITH Symposium in New York, New York.

Key Points: 
  • The session will be held on Wednesday, November 15th, at the 50th annual VEITH Symposium in New York, New York.
  • Professor Varcoe previously presented SWING Trial 12-month data on January 18th at the 35th Annual International Symposium on Endovascular Therapy (ISET) conference.
  • Sirolimus, a potent anti-inflammatory and anti-proliferative compound, has been used successfully in coronary drug-eluting stents.
  • The Sundance Sirolimus Drug-Coated Balloon is not available for sale anywhere in the world, and currently is for investigational use only.

Cleantech Blue-Zone Technologies Signs Agreement With Class 1

Retrieved on: 
Wednesday, November 1, 2023
Operating, Anesthetic, Environment, Inhalation, Partnership, Hospital, Collection, WAGs, Healthcare Facilities Accreditation Program, Pharmaceutical industry

Under this agreement, the two companies will work together to advance the methods of sustainable collection of WAGs emitted by healthcare facilities while reducing hazardous environmental waste in communities across North America.

Key Points: 
  • Under this agreement, the two companies will work together to advance the methods of sustainable collection of WAGs emitted by healthcare facilities while reducing hazardous environmental waste in communities across North America.
  • The agreement will increase Blue-Zone’s access to supply of collected WAGs through Class 1’s existing and new healthcare facility contracts.
  • Once delivered to Blue-Zone’s facility, the raw WAGs will be converted into a marketable anesthetic product using Blue-Zone’s unique, patented desorption and distillation processes.
  • “The more harmful WAGs we can remove from the environment in Canada and the United States, the better.

US Anesthesia Drugs and Devices Market Set to Reach $6.83 Billion in 2023, Driven by Growing Healthcare Expenditure - ResearchAndMarkets.com

Retrieved on: 
Monday, November 6, 2023
Pharmaceutical, Health, Medical Devices, Patient, Headache, Ageing, Anesthesiology, Pain, KKR, Vomiting, Abdominal ultrasonography, Somnolence, Prevalence, AstraZeneca, Conditional sentence, Lidocaine, Anesthetic, Shivering, MAC, Envision Healthcare, Nausea, 3M, Abbott Laboratories, General Electric Company, SunMed BRT station, Growth, Fungal infection, TeamHealth, COVID-19, Inhalation, Risk, AbbVie, Device, Benzocaine, Consciousness, Becton, Dickinson and Company headquarters, Blackstone, Braun, Baxter International, Ventilation, Central nervous system, ICU Medical, ICU, Pharmaceutical industry, Dentistry, Bupivacaine, Prilocaine, Anesthesia, Ropivacaine

The US anesthesia drugs and devices market is divided into two primary segments: anesthesia drugs and anesthesia devices.

Key Points: 
  • The US anesthesia drugs and devices market is divided into two primary segments: anesthesia drugs and anesthesia devices.
  • Among these segments, anesthesia drugs currently hold the majority share, while the anesthesia devices segment is expected to experience substantial growth due to increased healthcare expenditure in the region.
  • In terms of types, the US anesthesia drugs market is categorized into General, Local, and other anesthesia.
  • The development of novel anesthesia drugs through pharmaceutical R&D is expected to create growth opportunities in the "other anesthesia drugs" segment.

Incheon National University Scientists Develop New Hydrogels for Wound Management

Retrieved on: 
Monday, November 6, 2023
DA, Polymerization, Engineering, Water, Catecholamine, Associate, Hyperoxia, Life, Human, Oxygen, Dopamine, Anesthetic, Coagulation, Wound healing, Research, Cell proliferation, Gel, KPA, Regeneration, Accident, Calcium peroxide, Gas, Incheon National University, GOTS, Toxicity, Suture, Infection, Hydrophobic light-activated adhesive, Adhesive, Silk

GWANGJU, South Korea, Nov. 6, 2023 /PRNewswire/ -- Wound management is essential to ensure a speedy and safe recovery, and tissue adhesive patches are an attractive option that can replace sutures and stapling. In a recent study, researchers from Korea developed a new type of gelatin-based tissue adhesive hydrogel that locally generates oxygen through a reaction mediated by calcium peroxide, which improves the adhesiveness of the material and greatly enhances the healing process.

Key Points: 
  • Open wounds, whether caused by accidents or from medical procedures like surgery, require proper management to speed up healing and prevent infections.
  • While sutures and staples are common wound closure methods, they can cause secondary tissue injuries, potentially leaking fluids and gases and requiring anesthetics.
  • Against this backdrop, a team of researchers from Korea, led by Associate Professor Kyung Min Park of Incheon National University set out to find an effective solution to these limitations.
  • The research team has high hopes for the potential of the GOTs to become a cost-effective solution for wound management in a clinical setting.

AANA Updates, Publishes Analgesia and Anesthesia Practice Considerations for The Substance Use Disorder Patient

Retrieved on: 
Wednesday, October 25, 2023
Cannabis, Pain, Patient, CRNA, History, Substance use disorder, Anesthetic, Multimodal, Factitious disorder, SUD, Nausea, Trauma, Multimedia, Death, Learning, DNP, AANA, Pain management, Crna, CPPS, Anesthesia, Conditional sentence, Memory, Nursing

"Effective analgesia and anesthesia care for the substance use disorder patient involves managing the physiological and psychological implications of substance use, mitigating withdrawal, and preventing relapse," said Daniel King, DNP, CRNA, CPPS, AANA Practice Committee chair.

Key Points: 
  • "Effective analgesia and anesthesia care for the substance use disorder patient involves managing the physiological and psychological implications of substance use, mitigating withdrawal, and preventing relapse," said Daniel King, DNP, CRNA, CPPS, AANA Practice Committee chair.
  • "The purpose of these practice considerations is to offer evidence-based guidance for the anesthesia professional in the provision of optimally safe care for the SUD patient.
  • AANA's updated practice considerations offer insight on providing optimal care for all patients with substance abuse disorder, with special emphasis for patients using cannabis.
  • Other benefits of multimodal analgesia include early mobilization, decreased length of stay, faster functional recovery, decreased pain scores, and increased patient satisfaction.

Michigan Association of Nurse Anesthetists selects Jodie Emerson as new president for 2023-24 term

Retrieved on: 
Thursday, October 19, 2023
CRNA, Human, Certified Registered Nurse Anesthetist, Anesthetic, Trauma, MyMichigan Medical Center-Midland, Michigan Association of Broadcasters, MANA, United States Department of Veterans Affairs, Society, SOFA, Crna, Patient, Anesthesia, Emerson, Tuskegee Veterans Administration Medical Center, ICU, Nursing

LIVONIA, Mich., Oct. 19, 2023 /PRNewswire/ -- Jodie Emerson DNP, CRNA, a Certified Registered Nurse Anesthetist (CRNA), is the new president of the Michigan Association of Nurse Anesthetists (MANA) for the 2023-24 term.

Key Points: 
  • LIVONIA, Mich., Oct. 19, 2023 /PRNewswire/ -- Jodie Emerson DNP, CRNA, a Certified Registered Nurse Anesthetist (CRNA), is the new president of the Michigan Association of Nurse Anesthetists (MANA) for the 2023-24 term.
  • She also is an independent contractor who provides anesthesia care across Michigan.
  • Michigan has one of the highest numbers of CRNAs nationally, with approximately 2,700 nurse anesthetists currently practicing.
  • Emerson previously served as president elect of MANA during the 2022-23 term.

Drug Shortages Impacting Nearly All Pharmacies, Pharmacy Technician Certification Board Survey Finds

Retrieved on: 
Thursday, September 21, 2023
Pharmacy technician, Diabetes, Lidocaine, Workflow, Pharmacy, Weight loss, Collaboration, ADHD, Anesthetic, Patient, Supply, Health, Grocery store, Nursing, Tirzepatide

WASHINGTON, Sept. 21, 2023 /PRNewswire/ -- In a recent online survey conducted by the Pharmacy Technician Certification Board (PTCB) of Certified Pharmacy Technicians (CPhTs) who hold PTCB's Supply Chain and Inventory Management Certificate , nearly 96 percent of respondents said their pharmacy faces drug shortages.

Key Points: 
  • WASHINGTON, Sept. 21, 2023 /PRNewswire/ -- In a recent online survey conducted by the Pharmacy Technician Certification Board (PTCB) of Certified Pharmacy Technicians (CPhTs) who hold PTCB's Supply Chain and Inventory Management Certificate , nearly 96 percent of respondents said their pharmacy faces drug shortages.
  • Pharmacy Technician Certification Board (PTCB) survey shows nearly all pharmacies facing disruptive drug shortages.
  • When a comparable drug is not available, pharmacy technicians utilize their pharmacy's compounding services (28.79%) or refer to another compounding pharmacy (6.06%).
  • "It's no surprise that pharmacy technicians are actively working on solutions to mitigate drug shortages for their patients.